Steven Feldman to Antifungal Agents
This is a "connection" page, showing publications Steven Feldman has written about Antifungal Agents.
Connection Strength
1.141
-
Taheri A, Davis SA, Huang KE, Feldman SR. Onychomycosis treatment in the United States. Cutis. 2015 May; 95(5):E15-21.
Score: 0.501
-
Satyaprakash A, Balkrishnan R, Camacho FT, Jayawant SS, Fleischer AB, Feldman SR. Quality of dermatologic care delivered by physician assistants: an analysis of prescribing behavior for the combination antifungal agent clotrimazole-betamethasone. Arch Dermatol. 2007 Dec; 143(12):1591-2.
Score: 0.300
-
Krob AH, Fleischer AB, D'Agostino R, Feldman SR. Terbinafine is more effective than itraconazole in treating toenail onychomycosis: results from a meta-analysis of randomized controlled trials. J Cutan Med Surg. 2003 Jul-Aug; 7(4):306-11.
Score: 0.221
-
Draelos ZD, Feldman SR, Butners V, Alió Saenz AB. Long-term safety of ketoconazole foam, 2% in the treatment of seborrheic dermatitis: results of a phase IV, open-label study. J Drugs Dermatol. 2013 Jan; 12(1):e1-6.
Score: 0.107
-
Smith ES, Fleischer AB, Feldman SR, Williford PM. Characteristics of office-based physician visits for cutaneous fungal infections. an analysis of 1990 to 1994 National Ambulatory Medical Care Survey Data. Cutis. 2002 Mar; 69(3):191-8, 201-2.
Score: 0.013